Investor Presentation Q1 2019
TSXv: NDVA 2/22 I N V E S T O R P R E S E N TAT I O N The information contained herein, together with any amendments or supplements and any other information that may be furnished by the company, includes forward-looking information. Such information is based on assumptions as to future events that are inherently uncertain and subjective. The company makes no representation or warranty as to the attainability of such Forward assumptions, including the completion of a fjnancing or as to whether future results will occur as projected. Looking It must be recognized that the projections of the Statement company’s future performance are necessarily subject to a high degree of uncertainty, that actual results can be expected to vary from the results projected and that such variances may be material and adverse. Prospective investors are expected to conduct their own investigation with regard to the company and its prospects. This presentation does not constitute an ofger to sell or a solicitation of an ofger to buy any security.
TSXv: NDVA 3/22 I N V E S T O R P R E S E N TAT I O N Sales have begun through the Ontario Cannabis Store (OCS.ca) Executive Fully funded expansion to 40,000 square feet drives revenue growth Summary 70 tonne extraction facility to produce distillate for INDIVA, Bhang, Deep Cell and other products Capitalization: Basic Shares Outstanding ............................ 83.0mm Warrants: .............................. 28.3mm • Award-winning cannabis products Options: .................................... 4.7mm Convert: ................................... 6.9mm • State-of-the-art GMP-standard indoor Fully Diluted Shares production facility Outstanding .......................... 122.9mm • Experienced Master Grower with award-winning strains and loyal Balance Sheet: 1000+ patient base Cash (Sept. 30, 2018) ..... $24.3mm • Experienced management team Management and Insider Ownership ....................... 17%
TSXv: NDVA 4/22 I N V E S T O R P R E S E N TAT I O N 2019 Roadmap OCS *3 New Capacity: *5 additional Capacity: *Extraction facility operational Processing & **Farm Gate Product fmower 1,000kg annual fmower 3,000kg annual Capacity: 70 tonnes biomass, commercial Store Call rooms fmower production rooms fmower production 4 million grams distillate kitchen operational Q2 Q4 Q1 Q3 2019 2019 2019 2019 Introduction of Dry Flower, Introduction of Vape Pens, Bhang For sale at OCS.ca Tinctures & Gel Capsules Chocolate, Chewable Gems, Ruby Sugar & Salt * Pending Health Canada approval ** Pending AGCO approval
TSXv: NDVA 5/22 I N V E S T O R P R E S E N TAT I O N INDIVA International Global Family Brands Our aim is to bring our family of Brands of global cannabis brands to Canadians, and as marijuana laws liberalize in Canada and internationally, Indiva will use its Canadian operations as a platform to open new markets for its products. POWERED BY INDIVA POWERED BY INDIVA
TSXv: NDVA 6/22 I N V E S T O R P R E S E N TAT I O N INDIVA Products Stand for Quality
TSXv: NDVA 7/22 I N V E S T O R P R E S E N TAT I O N Products Powered by INDIVA Bhang TM is the most awarded line of cannabis chocolate bars available in the world.
TSXv: NDVA 8/22 I N V E S T O R P R E S E N TAT I O N Products Powered by INDIVA Ruby TM sugars and salts are ‘Flexible Edible’ cannabis products created to easily incorporate into your everyday food and drink.
TSXv: NDVA 9/22 I N V E S T O R P R E S E N TAT I O N Daily Weekly Monthly Occasionally Non-Consumers Potential Customer 7% 4% 17% SIZE AND MAKEUP OF THE CANADIAN 3% RECREATIONAL MARKET 8% According to the Deloitte Survey, the size of the Canadian recreational cannabis market could be as much as $8.7 billion per year, or similar to the size of the Canadian Recreational spirit market. 61% Cannabis Source: Deloitte, PBO Users (Thousands) Consumption (Metric Tonnes) $7-10 Billion Domestic Market 1600 1200 Opportunity! 375 800 600 * 2.6 million Canadians admit to use in last 250 12 months 200 * Represents <5% of total consumption 20 10 Once Less than once a month 1-3 Times per month At least once a week Daily ANNUAL CANNABIS USERS Source: PBO AND CONSUMPTION
TSXv: NDVA 10/22 I N V E S T O R P R E S E N TAT I O N Health Canada’s Projected Registered Patients Actual Registered Patients 450,000 400,000 Registered Patients September 2018: registered 350,000 patients exceeds Health 300,000 Canada’s 2023 projection 250,000 200,000 150,000 Growing 100,000 50,000 Demand 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 for Medical GROWTH RATE OF MEDICINAL CANNABIS USERS IS HIGHER THAN EXPECTED Cannabis Health Canada projected 450,000 patients will be using cannabis at $1.3 billion annual 18,086 revenue by 2024. physicians have authorized patient access to medicinal marijuana 6,000,000 5,000,000 342,103 4,000,000 registered patients 3,000,000 in total to date 2,000,000 (~80% from ON and AB) 1,000,000 Multiple Risk of Migraine Life Stress Sclerosis Epilepsy Cancer Low BMI Severe Pain Depression Headaches Insomnia Anxiety Arthritis Hypertension (Elevated) POTENTIAL MARKET Source: Health Canada, Statistics Canada, Canadian Community Health Survey, medicalmarijuana.ca
TSXv: NDVA 11/22 I N V E S T O R P R E S E N TAT I O N Number of licences issued YT 0 by province NU NT 0 0 NL 1 Supply of BC 32 AB Cannabis MB QC 9 2 12 PE SK 2 ON 4 73 OVER-supply NS 4 of dry fmower NB 3 just around the corner! Licensed Producer Production Capacity Tonnes Aurora Cannabis ............................................... 700 Canopy Growth ............................................... 500 Aphria ............................................... 255 Tilray ............................................... 200 The Green Organic Dutchman .................................................. 95 Cronos Group ................................................. 135 OrganiGram .................................................. 113 HEXO ................................................ 108 CannTrust ................................................ 105 Emerald Health Therapeutics ................................................ 100 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – TOTAL (metric tonnes) ............................................ 2,411 Source: Mackie Research, 420intel.com
TSXv: NDVA 12/22 I N V E S T O R P R E S E N TAT I O N FINANCE & CORPORATE DEVELOPMENT CREATIVE & BRAND DESIGN – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – Niel Marotta Tom Borowicz President & CEO, Director, Founder Chief Brand Offjcer • Managed over $1 Billion across several • Over 30 years of experience in marketing, industries Involved in capital raises and M&A branding, print/digital advertising and design transactions exceeding $1 Billion with Fortune 500 companies FINANCE PRODUCTION – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – Jennifer Welsh, CPA Pete Young Talented & Chief Financial Offjcer Master Grower, Founder • Managed a global fjnance team for eight • Grow Team: 15+ years of experience producing Experienced years as Corporate Controller of a TSX listed medicinal strains for hundreds of patients company • International recognition and multiple product Team • Former consultant for a publicly traded LP awards CORPORATE DEVELOPMENT PROJECT MANAGEMENT – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – Jamie Rifg, P.Eng Jose Laurentino VP Corporate Development • 20+ years in agricultural project development including indoor and greenhouse expertise 15+ years experience in capital markets and institutional sales
Recommend
More recommend
